研发
精心研发,造福患者
我们的研发团队努力发现、开发和提供能够改变患者人生的药物,为存在高度未满足需求的医疗领域建立新标准。用我们的创新药物消灭让人闻之色变的严重疾病:癌症、心脏和免疫系统以及血液疾病。它绝不简单,但绝对有趣。在这里,你将改写规则,抗击艰巨挑战,创造奇迹。
Explore careers in Research & Development
我们为在肿瘤学、血液学、免疫学、心血管和神经科学等核心治疗领域取得的进步感到自豪。我们前景广阔的多样化在研管线专注研究存在出色机会的治疗领域,我们相信能为这些领域的患者提供变革性药物。在开发下一代突破性治疗领域,BMS 是研发人员的不二之选。在这里,你不仅能体验有趣的工作、激动人心的职业发展,还将与来自各个领域的杰出队友合作。它可能彻底改变你的职业生涯。
Our next neuroscience breakthrough need authors
Neurological and neuropsychiatric conditions are complex and present significant challenges in healthcare today. These disorders are often long-lasting and difficult to treat, causing a major impact on patients, caregivers, and families.
At Bristol Myers Squibb, you will be part of a team working to address some of the toughest neurological issues, creating real change for those affected. Our mission is to lead in innovation by developing new treatments that can slow the progress of these diseases and improve quality of life for patients and those who support them.
Discover the innovation of RayzeBio.
RayzeBio is a dynamic biotechnology company headquartered in San Diego, CA. Launched in late 2020 and recently acquired by Bristol Myers Squibb (BMS) as a wholly owned subsidiary, the company is focused on improving survival of people with cancer by harnessing the power of targeted radioisotopes.
RayzeBio will operate as a standalone entity within the BMS organization, maintaining its biotech culture with the opportunity to leverage the best-in-class oncology capabilities of BMS. RayzeBio is developing innovative drugs against targets of solid tumors.


